bsm-54572R [Primary Antibody]
Phospho-Tau(S396) Monoclonal Antibody
www.biossusa.com
support@biossusa.com
800.501.7654 [DOMESTIC]
+1.781.569.5821 [INTERNATIONAL]
DATASHEET

Host: Rabbit

Target Protein: Phospho-Tau(S396)

Modification Site: Ser396

Clonality: Monoclonal

Isotype: IgG

Entrez Gene: 4137

Swiss Prot: P10636

Source: Synthetic phospho-Peptide corresponding to residues surrounding Ser396 of human Tau.

Purification: Purified by Protein A.

Storage Buffer: 0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.

Storage: Store at +4°C after thawing. Aliquot store at -20°C or -80°C. Avoid repeated freeze / thaw cycles.

Background:

Tau proteins are important Promotes microtubule assembly and stability, and might be involved in the establishment and maintenance of neuronal polarity. The C-terminus binds axonal microtubules while the N-terminus binds neural plasma membrane components, suggesting that tau functions as a linker protein between both. Axonal polarity is predetermined by tau localization (in the neuronal cell) in the domain of the cell body defined by the centrosome. The short isoforms allow plasticity of the cytoskeleton whereas the longer isoforms may preferentially play a role in its stabilization. Tau proteins subcellular located in the axons of neurons, in the cytoso l and in association with plasma membrane components. It expressed in neurons. PNS-tau is expressed in the peripheral nervous system while the others are expressed in the central nervous system.

Size: 100µL

Concentration: Lot Dependent

Predicted Molecular Weight: 80


Cross Reactive Species: Human
Mouse
Rat

For research use only. Not intended for diagnostic or therapeutic use.

PRODUCT SPECIFIC PUBLICATIONS
  • Lu Tianming. et al. Cordyceps sinensis relieves non-small cell lung cancer by inhibiting the MAPK pathway. CHIN MED-UK. 2024 Dec;19(1):1-14Read more>>
VALIDATION IMAGES

25 ug total protein per lane of various lysates (see on figure) probed with RhoA monoclonal antibody, unconjugated (bsm-54572R) at 1:1000 dilution and 4°C overnight incubation. Followed by conjugated secondary antibody incubation at r.t. for 60 min.